Clinical study of low-dose aspirin combined with metoprolol on the blood coagulation and cardiac function of the elderly patients with chronic heart failure
吕先光,吴伯祥,朱茜,杨远斌,李进兵,王应立,徐明
DOI: https://doi.org/10.7501/j.issn.1674-5515.2014.04.016
2014-01-01
Abstract:Objective To explore the clinical efficacy of low-dose aspirin combined with metoprolol on elderly patients with chronic heart failure. Methods Eighty-four cases of elderly patients with chronic heart failure who came to Clinic Department of Resthome for Retired Veterans in Guangzhou from July 2011 to July 2013 for treatment were selected as the sample. The patients were divided into treatment group and control group according to stratified randomization method, and there are 42 cases in each group. The treatment group was po administered with low-dose aspirin enteric-coated metformin hydrochloride, once 75 mg, once daily, and combined with Metoprolol Tablets, once 6.25 mg, twice daily, along with conventional therapy, while the patients in the control group were given conventional therapy only. Both groups were treated for 4 weeks. The plasma P-selectin, von Willebrand factor, D-dimer, brain natriuretic peptide, and cardiac function improvement of the two groups were compared before and 4 weeks after the therapy. Results After the treatment, plasma P-selectin, von Willebrand factor, and D-dimer were decreased, and there were significant differences before and after the treatment(P0.05). After the treatment, plasma P-selectin, von Willebrand factor, and D-dimer of the patients in the treatment group were lower than those of the patients in the control group, and the differences between the two groups had statistical significance(P0.05). Within 1-4 weeks after the treatment, brain natriuretic peptide of the patients in the two groups was decreased, and the differences before and after the treatment were statistically significant(P0.05). After the treatment, the brain natriuretic peptide of the patients in the treatment group was lower than that of the patients in the control group during the same period, and the differences between the two groups were statistically significant(P0.05). After the treatment, the total effective rates in the treatment and control groups were 85.71% and 57.14%. And there were significant differences between the two groups(P0.05). Conclusion Low-dose aspirin combined with metoprolol along with conventional therapy can be better at antithrombotic and promoting the recovery of cardiac function, which is worth clinical development and application.